223 results on '"García-Marco, José A."'
Search Results
2. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL
3. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
4. Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative
5. Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia
6. The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL
7. Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study
8. MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest
9. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
10. Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
11. CCR Translation for This Article from Induction of B-Chronic Lymphocytic Leukemia Cell Apoptosis by Arsenic Trioxide Involves Suppression of the Phosphoinositide 3-Kinase/Akt Survival Pathway via c-jun-NH2 Terminal Kinase Activation and PTEN Upregulation
12. Supplementary Data from Induction of B-Chronic Lymphocytic Leukemia Cell Apoptosis by Arsenic Trioxide Involves Suppression of the Phosphoinositide 3-Kinase/Akt Survival Pathway via c-jun-NH2 Terminal Kinase Activation and PTEN Upregulation
13. Sequential Quantification of T-Cell Receptor Excision Circles (TREC) and K-Deleting Recombination Excision Circles (KREC) in Allogeneic HSCT Recipients
14. Mantle cell lymphoma: Towards a personalized therapeutic strategy?
15. Haplo-Cord Transplantation Using CD34+ Cells from a Third-Party Donor to Speed Engraftment in High-Risk Patients with Hematologic Disorders
16. PLCG1 mutations in cutaneous T-cell lymphomas
17. Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World Setting in Spain: An Update of the Venares Study
18. Differences in Clinical Course and Management of Sars-CoV2 Infection in Patients with Chronic Lymphocytic Leukemia between the Sequential Pandemic Phases: An Eric Study
19. Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia
20. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and COVID-19: A study of ERIC, the European Research Initiative on CLL
21. Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica
22. COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
23. Matrix Metalloproteinase-9 Promotes Chronic Lymphocytic Leukemia B Cell Survival through Its Hemopexin Domain
24. Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)
25. TCL1A expression delineates biological and clinical variability in B-cell lymphoma
26. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults
27. Additional file 2 of Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia
28. Worldwide Examination of Patients with CLL Hospitalized for COVID-19
29. α4β1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells
30. HLA-partially matched cellular therapy (stem-cell microtransplantation) for acute myeloid leukaemia: description of four cases
31. 79 - Sequential Quantification of T-Cell Receptor Excision Circles (TREC) and K-Deleting Recombination Excision Circles (KREC) in Allogeneic HSCT Recipients
32. Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab
33. Matrix metalloproteinase-9 induces a pro-angiogenic profile in chronic lymphocytic leukemia cells
34. High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance
35. Propuesta de Plan de adaptación de las instalaciones del Grupo de Caballería Ligero Acorazado 'Reyes Católicos' II de La Legión a la Brigada Experimental 2035
36. α4β1 integrin associates with VEGFR2 in CLL cells and contributes to VEGF binding and intracellular signaling
37. Prostatic-Like Syndrome in a Woman with Chronic Lymphocytic Leukemia: Sequential Kinase Inhibitor Therapy
38. Enfermedad residual mínima en la leucemia linfática crónica
39. Minimal residual disease in chronic lymphocytic leukaemia
40. A catalytically inactive gelatinase B/MMP-9 mutant impairs homing of chronic lymphocytic leukemia cells by altering migration regulatory pathways
41. Bone Marrow Infiltration at Diffuse Large B-Cell Lymphoma NOS Diagnosis: Comparative Study between PET, Histology and Flow Cytometry
42. Preliminary Results of Ibrutinib Followed By Ofatumumab Consolidation in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL): GELLC7 Trials from the Spanish Group of CLL (GELLC)
43. Actualización de las guías nacionales de consenso del Grupo Español de Leucemia Linfocítica Crónica para el tratamiento y seguimiento de la leucemia linfocítica crónica
44. Update of the Grupo Español de Leucemia Linfocítica Crónica clinical guidelines of the management of chronic lymphocytic leukemia
45. Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9
46. Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells
47. Laboratories Can Reliably Detect Clinically Relevant Variants in the TP53Gene below 10 % Allelic Frequency: A Multicenter Study of ERIC, the European Research Initiative on CLL
48. Leukemogenesis in Seven Donor Cell Derived Myeloid Neoplasms Patients. Whole Exome Sequencing Reveals Clonal Dynamics
49. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways
50. Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.